New manuscript out as preprint! We performed in-depth functional profiling of 400 individuals to elucidate how biological variation in cellular processes link to treatment outcomes of cholesterol-lowering medication. @HelsinkiUniMed@helsinkiuni@samrip https://t.co/gdR1VX7GqP
And the best presenting company award from 200+ applicants goes to… Moncyte! 💥💥💥
Thank you to all investors for your vote of confidence at the European Healthtech Investment Forum, a go-to-event for any Life Science company.
@HelsinkiUniMed@LabPfisterer@BusinessFinland
Welcome to the Meeting of the Finnish Atherosclerosis Society on 11-12th May in Porvoo! Topics range from lipid trafficking, lipoprotein metabolism to genetic causes of cardiovascular disease. Submit your abstract until March 15th! More info 👇
https://t.co/T5MCXYtTtt
We are using imaging to shed light on why some people have high blood cholesterol and why they respond differently to treatment. Also, we use imaging to unravel cellular consequences of genetic mutations. Imaging is great! @HelsinkiUniMed@helsinkiuni https://t.co/48SYNzyehm
To lead the 🆕 wave of innovation, we need 🇪🇺 Innovative Universities!
Inspired by the work done by @helsinkiuni🎓, member @Una_Europa🇪🇺Alliance, to train talents & support innov’ startups’ founders @UH_Innovation.
Thank you Rector @SariLindblom & @JariStrandman for our talk!
(Please RT) We are looking to recruit a #postdoc with expertise in either biochemistry/structural biology or cell biology! Join us to study #actin dynamics, cell migration, and morphogenesis. @BIOTECH_UH@helsinkiuni
https://t.co/8a9EM5ONH5
This massive study combined evidence for the link between autoimmune diseases and dementia using 6 different big-data approaches.
The work was lead by @jlindbohm and @ninajmars with contributions from @pyrysipila, @heikorunz, @Gill_Livingston, Ramnik Xavier and many others
@Startup100_fi Please Note, the hottest soon-to-be healthTech startup and spinout of the University of Helsinki: Moncyte 💥 the next level decision making tool to revolutionize the way high cholesterol patients are treated and save lives.
Thank you Voima Ventures for your faith in NADMED! We are looking forward to a shared journey in opening new vistas in personalized health care and improving lives of millions of people! #NAD#NADMED#nadscience#metabolism#mitochondria
https://t.co/DFSqb6FqXE
📢We are looking for a colleague!
A 3-year funded postdoc position available in my group to explore the molecular mechanisms of the health benefits of exercise in cardiometabolic disease with a twist of vascular biology🔬🧫🧬 DL 31.10. Please RT!
https://t.co/BMCYcntWIZ
Wonderful experience and memories from @NLSDays! 💥💥💥 From pitching Moncyte to discussing innovation at @SPARKFinland panel discussion, meeting investors and all my amazing startup colleagues that are making this experience and atmosphere so positive and fun. Thank you! 🧡